Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice volume! Shorties selling to each other
Sinking ship concerning share price i agree! But this Liberty thing can get out of the mud and run. Not bailing for .00001 cause i need stories to tell at the nursing home. Liberty supplies nursing homes in Florida? Indica i think, Thanks
Everything down? Something about a tweet
TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has secured Health Canada approval for 27 acres of low-cost, outdoor cultivation on its Strathroy, Ontario property. The Company will commence planting more than 20,000 clones in early June with plans to harvest in fall 2019, increasing potential production output by an additional 27,000 kgs.
With a combined indoor and outdoor production footprint of over 5.2 million sq. ft. and projected total potential annual output of 150,000 kgs of cannabis by 2020, WeedMD is now positioned to become one of Canada’s largest cannabis producers.
“Our ability to scale, coupled with our team’s proven experience in growing our proprietary genetics outdoors, positions us as a first-mover in the industry,” said Keith Merker, CEO of WeedMD. “We have put together the most compelling outdoor cultivation plan in the industry and this licence is the final piece of that plan to fall into place.”
WeedMD Outdoor Cultivation &
Halted pending news
Outdoor Grow. 27-acre, low-cost, outdoor grow operation ready to plant, pending licensing. With expansion capabilities to more than 100 acres for a total yield of more than 100,000 kgs of outdoor cannabis planned for 2020.
Facilities and Production Update. An additional 10 hybrid cultivation rooms, each 10,000 sq. ft., are complete and are expected to be licensed once the outdoor licence is secured. The Company is also now in the late stages of completing the retrofit of two large traditional greenhouse rooms that will add more than 300,000 sq. ft. in 2019.
Licensing and Packaging Efficiencies. Secured a Health Canada licence amendment for an additional processing area equipped with semi-automated packaging lines at its Aylmer facility to increase speed to market and drive costs lower. Also secured a processing licence at the Strathroy facility.
Extraction Initiative. WeedMD is currently converting its fully-licensed Aylmer facility into a large-scale cannabis extraction and processing hub with an annual capacity to process more than 200,000 kgs of biomass.
Operating Metrics Improve.Margins continue to improve through increasing yields, economies of scale beginning to be realized as production expands, and a focus on refining processes.
Supply and Distribution Agreements. WeedMD secured additional provincial distribution agreements with Manitoba and Saskatchewan. Shipping to a total of six provinces across the country, the Company is now able to reach about 70% of Canada’s projected adult-use market.
Retail Initiative. WeedMD partnered with Pioneer Cannabis and Pita Pit to pursue opportunities in cannabis retail. A Master Cannabis Retail and Licensing Agreement was signed with an Ontario cannabis retail lottery winner who will own and operate the first Pioneer Cannabis store located at 1200 Brant Street in Burlington, Ontario.
We continue to deliver consistent improvement in our results, quarter-over-quarter,” said Nichola Thompson, CFO of WeedMD. “With the successful harvests from six additional grow rooms licensed at the end of 2018 now coming to market, we expect significant revenue increases throughout the balance of the year.”
For the three months ended March 31, 2019, WeedMD recorded net sales of $3.3M, representing a quarter-over-quarter increase of 23%.
The Company sold 793 kgs of dried cannabis, representing an increase of 46% from the previous quarter.
Improved gross profit margin to 15% (before changes in fair value).
The Company holds $13.9M of inventory and biological assets as of March 31, 2019, an increase of $5.9M or 74% from the prior quarter.
The all-in weighted average cost per gram for Q1 2019 was $2.90, compared to $3.28 for Q4 2018 and $3.66 in Q1 2018. This is inclusive of all costs, direct and indirect, to produce and package a gram of cannabis.
WeedMD purchased the 98-acre property in Strathroy where its 610,000 sq. ft. greenhouse facility and associated infrastructure reside, as well as the neighbouring 60-acre property. The Company funded the transaction with a $39M credit facility from BMO.
Fully-licensed facility to be optimized for extract and concentrate production with capacity of more than 200,000 kgs of biomass by 2020
TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (WDDMF) (4WE.F) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it is converting its fully-licensed 26,000 sq. ft. Aylmer, Ontario facility to a large-scale cannabis extraction and processing operation.
“WeedMD is optimizing its two licensed facilities to allow each to focus on a core vertical and to streamline our operations. We are transitioning the Aylmer site to produce a wide range of extracts and concentrates,” said Keith Merker, CEO of WeedMD. “All cultivation has been consolidated to our greenhouse and outdoor Strathroy facility, which is delivering consistently improving yields at increasingly competitive costs.”
yea, getting a little frustrated but I never sell underwater.
Volume 11,000, Eustace says "stupid dog"
13,000 WTF
Volume under 13,00? WTF
lots of comments saying CFO & CEO wouldnt be filled if merger acquisition was in the works?
I say YEs, just getting out of the garbage pit called OTC will help
Organigram to invest $15 million in industry-leading infused chocolate innovation
?
CNW GroupMay 20, 2019, 6:00 a.m. EDT
Company positioning itself to compete within expected largest cannabis edibles segment
MONCTON, NB, May 20, 2019 /CNW/ - Anticipating the legalization of adult-use cannabis edibles, and ready to demonstrate a leadership position in the edibles market, Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce a $15 million investment commitment in a high-speed, high-capacity, fully-automated production line with ability to produce an estimated 4 million kilograms of exceptional chocolate cannabis edibles per year. Organigram expects to take delivery of the line in the fall.
Puur puur Liberty done sunk
Ive not heard onebut seen lots of interview's
NO volume
Im not blaming management yet but something needs to be done. OTC sucks, this pps does not reflect future potential one bit
Strange ticker? Been here almost three years 12/19 and underwater most of it with lots of fantastic news along the way!
OMG, scam TRTC has a higher share price! Maybe smoke a bull has a point
ABC has a billion shares and drunk on dilutuon
By kicking ass and making money!
In the old days they could drop this 10%? Goooo away shorts!
He did!!!!!!! And short typing fingers
We know you meant THC, thanks
What about technical requirements?
What would it take? Manipulation getting so old
I get it, my money has been stuck for 2 years
I saw a post saying Canopy 10 times rev with 100 times market cap
The market is a scam not WeedMD! Thanks for ur DD
I thought they were leasing the building? What was the 94 mill mentioned
and this
"They planned these quarter report prefect. Q1 is at the end of next month. They new pulling out of Canada would have a sell off. With them coming out with Q1 2019 in 30 days tells me they will crush earnings. I’m buying every share I can."
i copied this from Yahoo
"I am of two minds.
The 1Q 2019 revenue is significant and suggests SNN will make or exceed 2019 revenue guidance (impressive compared to higher cap competitors).
Am I correct that for this revenue SNN currently does not grow their own but instead buys from 3rd parties? Replacing 3rd party purchases with their own product might improve margins but will not increase revenue.
I like the plan/capacity to extract and market oils. Economies of scale in a higher margin product is a winner.
I never thought it made sense to grow in the Canadian high cost indoor producer environment. With adult /recreational market developing I think medicinal market days are numbered (so the high cost doc/clinic patient driver will be a loser).
I get the shelf space challenge but I don’t believe in the value of grow to table vertical intervention"